We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $246M
1-Year Est. Return 35.95%
This Fund
S&P 500
This Quarter Est. Return
+10.64%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
AUM
$245M
AUM Growth
+$18.2M
Cap. Flow
+$2.74M
Cap. Flow %
1.12%
Top 10 Hldgs %
66.41%
Holding
667
New
60
Increased
182
Reduced
81
Closed
82

Sector Composition

1 Healthcare 22.08%
2 Financials 4.47%
3 Technology 3.55%
4 Industrials 1.31%
5 Consumer Discretionary 1.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVV icon
1
iShares Core S&P 500 ETF
IVV
$891B
$75.6M 30.79%
110,309
+1,132
+1% +$769K
EFV icon
2
iShares MSCI EAFE Value ETF
EFV
$26B
$15.9M 6.49%
223,010
+769
+0.3% +$53.4K
IWM icon
3
iShares Russell 2000 ETF
IWM
$82.6B
$13.2M 5.37%
53,583
+28
+0.1% +$6.88K
AXGN icon
4
Axogen
AXGN
$2.12B
$11.3M 4.59%
343,940
+158,855
+86% +$3.91M
IJR icon
5
iShares Core S&P Small-Cap ETF
IJR
$111B
$10.3M 4.21%
85,879
+1,652
+2% +$198K
VOO icon
6
Vanguard S&P 500 ETF
VOO
$984B
$9.84M 4.01%
15,685
-23
-0.1% -$14.3K
IUSV icon
7
iShares Core S&P US Value ETF
IUSV
$27.2B
$7.88M 3.21%
76,800
+312
+0.4% +$31.6K
NEO icon
8
NeoGenomics
NEO
$1.93B
$6.67M 2.72%
567,334
+167,000
+42% +$1.8M
WFC icon
9
Wells Fargo
WFC
$267B
$6.39M 2.61%
68,611
-6,208
-8% -$539K
CNTA
10
DELISTED
Centessa Pharmaceuticals
CNTA
$5.92M 2.41%
236,785
-500
-0.2% -$12.7K
ANAB icon
11
AnaptysBio
ANAB
$1.6B
$4.56M 1.86%
94,050
-41,000
-30% -$1.6M
DWAS icon
12
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$455M
$4.37M 1.78%
45,196
+192
+0.4% +$18.3K
IJH icon
13
iShares Core S&P Mid-Cap ETF
IJH
$123B
$3.83M 1.56%
58,067
+466
+0.8% +$30.5K
ATRC icon
14
AtriCure
ATRC
$1.8B
$3.31M 1.35%
83,720
-5
-0% -$183
SIBN icon
15
SI-BONE Inc
SIBN
$786M
$3.15M 1.28%
159,832
+135,232
+550% +$2.35M
TLT icon
16
iShares 20+ Year Treasury Bond ETF
TLT
$41.9B
$3.1M 1.26%
35,511
+420
+1% +$37.6K
NVDA icon
17
NVIDIA
NVDA
$5.02T
$2.17M 0.88%
11,618
-116
-1% -$21.6K
AAPL icon
18
Apple
AAPL
$4.89T
$2.15M 0.88%
7,924
-484
-6% -$130K
LLY icon
19
Eli Lilly
LLY
$1.04T
$1.85M 0.75%
1,720
+2
+0.1% +$1.91K
MSFT icon
20
Microsoft
MSFT
$2.98T
$1.79M 0.73%
3,710
+33
+0.9% +$16.5K
HCAT icon
21
Health Catalyst
HCAT
$168M
$1.77M 0.72%
741,482
+431,200
+139% +$1.18M
TRV icon
22
Travelers Companies
TRV
$71.8B
$1.62M 0.66%
5,588
+12
+0.2% +$3.38K
ORGO icon
23
Organogenesis Holdings
ORGO
$344M
$1.57M 0.64%
303,029
+10,000
+3% +$48.5K
MMM icon
24
3M
MMM
$84.4B
$1.56M 0.64%
9,734
-30
-0.3% -$4.91K
EWTX icon
25
Edgewise Therapeutics
EWTX
$4.11B
$1.32M 0.54%
53,179

Similar funds

HighMark Wealth Management's Q4 2025 Portfolio in Review

As of Q4 2025, HighMark Wealth Management held 667 positions worth $245M, up 8% from $227M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

HighMark Wealth Management's Q4 2025 filing shows 60 new, 182 increased, 81 reduced and 82 closed positions. Its largest new stake was 908 Devices: 241,000 shares worth $1.27M. The largest sale was Performant Healthcare Inc, an estimated $5.84M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 18% a quarter earlier, followed by Financials and Technology.

  • HighMark Wealth Management's largest Q4 2025 buy was 908 Devices: 241,000 shares worth $1.27M.
  • HighMark Wealth Management added most to Axogen in Q4 2025, an estimated $3.91M increase.
  • HighMark Wealth Management's biggest Q4 2025 reduction was AnaptysBio, cutting an estimated $1.6M.
  • HighMark Wealth Management fully exited Performant Healthcare Inc in Q4 2025, selling an estimated $5.84M.
  • HighMark Wealth Management's ten largest holdings make up 66% of its $245M portfolio in Q4 2025.
  • HighMark Wealth Management opened 60 new positions and closed 82 in Q4 2025.
  • HighMark Wealth Management's portfolio value rose 8% quarter-over-quarter to $245M.

Based on HighMark Wealth Management's 13F filing for Q4 2025, filed 5 Feb 2026.